Published on 22 May 2024 on GuruFocus.com via Yahoo Finance
Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)
On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a sale of 38,000 shares of the company. The transaction was filed on the same day with the SEC.
Warning! GuruFocus has detected 6 Warning Signs with AMRX.
Amneal Pharmaceuticals Inc (NASDAQ:AMRX) is a company that specializes in the development, manufacture, and distribution of generic and specialty pharmaceutical products. The company operates in several therapeutic areas, including oncology, pain management, central nervous system disorders, parasitic infections, and hormonal deficiencies.